Metastatic Cancer of prostate Tissues Release Methylglyoxal-Derived MG-H1 to be able to Reprogram Human Osteoblasts into a Dedifferentiated, Malignant-like Phenotype: A prospective Book Player in Prostate Cancer Bone Metastases.